These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2615928)

  • 1. Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients.
    Mathew RJ; Wilson WH
    Neuropsychobiology; 1989; 21(3):117-23. PubMed ID: 2615928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextroamphetamine-induced changes in regional cerebral blood flow.
    Mathew RJ; Wilson WH
    Psychopharmacology (Berl); 1985; 87(3):298-302. PubMed ID: 3936085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia.
    Daniel DG; Weinberger DR; Jones DW; Zigun JR; Coppola R; Handel S; Bigelow LB; Goldberg TE; Berman KF; Kleinman JE
    J Neurosci; 1991 Jul; 11(7):1907-17. PubMed ID: 2066768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine.
    Kornetsky C
    Arch Gen Psychiatry; 1976 Dec; 33(12):1425-8. PubMed ID: 793562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine-induced cerebral blood flow changes in schizophrenia.
    Mathew RJ; Wilson WH; Tant S
    Eur Arch Psychiatry Neurol Sci; 1986; 235(4):206-9. PubMed ID: 3699074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol.
    Angrist B; Sanfilipo M; Wolkin A
    Clin Neuropharmacol; 2001; 24(3):139-44. PubMed ID: 11391124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.
    Devous MD; Trivedi MH; Rush AJ
    J Nucl Med; 2001 Apr; 42(4):535-42. PubMed ID: 11337538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia.
    Goldberg TE; Bigelow LB; Weinberger DR; Daniel DG; Kleinman JE
    Am J Psychiatry; 1991 Jan; 148(1):78-84. PubMed ID: 1984711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment.
    van Kammen DP; Docherty JP; Bunney WE
    Biol Psychiatry; 1982 Feb; 17(2):233-42. PubMed ID: 7074181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia.
    Holcomb HH; Lahti AC; Medoff DR; Cullen T; Tamminga CA
    Neuropsychopharmacology; 2005 Dec; 30(12):2275-82. PubMed ID: 16034443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional cerebral blood flow in schizophrenic disorders.
    Kurachi M; Kobayashi K; Matsubara R; Hiramatsu H; Yamaguchi N; Matsuda H; Maeda T; Hisada K
    Eur Neurol; 1985; 24(3):176-81. PubMed ID: 3996455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms.
    Pogarell O; Koch W; Karch S; Dehning S; Müller N; Tatsch K; Poepperl G; Möller HJ
    Pharmacopsychiatry; 2012 May; 45 Suppl 1():S36-41. PubMed ID: 22565233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of d-amphetamine sulfate, caffeine, and high temperature on human performance.
    Lovingood BW; Blyth CS; Peacock WH; Lindsay RB
    Res Q; 1967 Mar; 38(1):64-71. PubMed ID: 5231902
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of amphetamine on visuospatial working memory performance in schizophrenia spectrum personality disorder.
    Kirrane RM; Mitropoulou V; Nunn M; New AS; Harvey PD; Schopick F; Silverman J; Siever LJ
    Neuropsychopharmacology; 2000 Jan; 22(1):14-8. PubMed ID: 10633486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia.
    van Kammen DP; Bunney WE; Docherty JP; Marder SR; Ebert MH; Rosenblatt JE; Rayner JN
    Am J Psychiatry; 1982 Aug; 139(8):991-7. PubMed ID: 7091448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood flow in schizophrenia.
    Dousse M; Mamo H; Ponsin JC; Tran Dinh Y
    Exp Neurol; 1988 Apr; 100(1):98-111. PubMed ID: 3350100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical responses to amphetamine exposure studied by pCASL MRI and pharmacokinetic/pharmacodynamic dose modeling.
    Nordin LE; Li TQ; Brogren J; Johansson P; Sjögren N; Hannesdottir K; Björk C; Segerdahl M; Wang DJ; Julin P
    Neuroimage; 2013 Mar; 68():75-82. PubMed ID: 23246855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral blood flow changes associated with amyl nitrite inhalation.
    Mathew RJ; Wilson WH; Tant SR
    Br J Addict; 1989 Mar; 84(3):293-99. PubMed ID: 2706385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333).
    Sprigg N; Willmot MR; Gray LJ; Sunderland A; Pomeroy V; Walker M; Bath PM
    J Hum Hypertens; 2007 Aug; 21(8):616-24. PubMed ID: 17443208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between regional cerebral blood flow and the Wisconsin Card Sorting Test in negative schizophrenia.
    Liu Z; Tam WC; Xie Y; Zhao J
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):3-7. PubMed ID: 11929565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.